Total Operating Expenses
Royalty Pharma Total Operating Expenses decreased by 71.1% to $67.54M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 98.3%, from $34.07M to $67.54M. Over 4 years (FY 2021 to FY 2025), Total Operating Expenses shows relatively stable performance with a -1.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase faster than revenue growth suggests declining operating margins, while slower growth indicates effective cost control.
Detailed definition
Total operating expenses represent the sum of all costs incurred to operate the business, excluding the cost of goods so...
Peer comparison
Used to calculate operating margin; peers in the healthcare sector monitor this closely to manage profitability against R&D requirements.
total_operating_expensesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$189.99M | $282.72M | $422.28M | $342.33M | $158.16M | $381.25M | $1.05B | $205.00M | $289.36M | $384.87M | $0.00 | $641.75M | $267.64M | -$170.38M | $232.13M | $34.07M | $368.87M | $182.14M | $233.61M | $67.54M |
| QoQ Change | — | +248.8% | +49.4% | -18.9% | -53.8% | +141.1% | +175.0% | -80.4% | +41.2% | +33.0% | -100.0% | — | -58.3% | -163.7% | +236.2% | -85.3% | +982.8% | -50.6% | +28.3% | -71.1% |
| YoY Change | — | — | — | — | +183.2% | +34.9% | +148.3% | -40.1% | +83.0% | +0.9% | -100.0% | +213.1% | -7.5% | -144.3% | — | -94.7% | +37.8% | +206.9% | +0.6% | +98.3% |
Total Operating Expenses at Other Companies
Frequently Asked Questions
- What is Royalty Pharma's total operating expenses?
- Royalty Pharma (RPRX) reported total operating expenses of $67.54M in Q1 2026.
- How has Royalty Pharma's total operating expenses changed year-over-year?
- Royalty Pharma's total operating expenses increased by 98.3% year-over-year, from $34.07M to $67.54M.
- What is the long-term trend for Royalty Pharma's total operating expenses?
- Over 4 years (2021 to 2025), Royalty Pharma's total operating expenses has grown at a -1.2% compound annual growth rate (CAGR), from $858.75M to $818.67M.
- What does total operating expenses mean?
- The total cost of running the business, including all non-production expenses.